心脏病患者的贫血管理:脏学观点
María Marques Vidas1,2, José Portolés1,2,3, Marta Cobo4,5
1Nephrology Department Hospital Universitario Puerta de Hierro-Majadahonda, IDIPHISA Madrid Spain.
Journal of the American Heart Association
|March 3, 2025
概括
心脏脏综合征 (CRS) 中贫血的管理是复杂的. 解决铁缺乏症和使用-葡萄糖共运输体2抑制剂可以改善心力衰竭 (HF) 和慢性病 (CKD) 患者的治疗结果.
科学领域:
- 心脏病学 心脏病学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 血液学 血液学 血液学
背景情况:
- 心力衰竭 (HF) 和慢性病 (CKD) 经常同时存在,形成心脏综合征 (CRS).
- 贫血是CRS的常见并发症,加剧了这两种情况,增加了发病率和死亡率.
- 由于多因素的原因和冲突的临床指导方针,在CRS中管理贫血是具有挑战性的.
研究的目的:
- 审查导致CRS贫血的因素的复杂相互作用.
- 讨论CRS患者治疗贫血和铁缺乏症的现有证据和争议.
- 在CRS的背景下,提出一项针对贫血的综合管理战略.
主要方法:
- 关于心脏病综合征,贫血和缺铁的研究的文献综述.
- 对链接HF,CKD和贫血的病理生理机制的分析.
- 评估当前的指导方针和最近的临床试验数据对CRS的贫血治疗.
主要成果:
- 在CRS的贫血是由不足的红蛋白,铁缺乏,减少红细胞寿命和炎症驱动的.
- 铁缺乏在HF和CKD中很普遍,对运动能力和生存有负面影响.
- -葡萄糖共传输体2抑制剂和静脉注射铁显示有好处,而红色素形成刺激剂对心血管有混合的结果.
结论:
- 同时管理HF,CKD和贫血是必要的.
- 一个拟议的算法涉及纠正缺铁,启动SGLT2抑制剂,并在必要时考虑ESA.
- 需要进一步的研究,以建立对CRS的最终贫血管理指南.
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
363
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
363
01:33Hormonal Regulation
32.8K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
32.8K
01:11Renal Failure: Dose Adjustments
54
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
54
01:22Heart Failure Drugs: Diuretics
324
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
324
01:25Antihypertensive Drugs: Direct Renin Inhibitors
468
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
468
01:27Dialysis
247
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
247